https://www.ncbi.nlm.nih.gov/pubmed/31619929 Hydatid cyst
Turk Pediatri Ars. 2019 Sep 25;54(3):173-178. doi: 10.14744/TurkPediatriArs.2019.24119. eCollection 2019.
Ten-year follow-up of children with hydatid cysts.
Eyüboğlu TŞ1, Gürsoy TR2, Aslan AT2, Pekcan S3, Budakoğlu Iİ4.
Abstract
in English, Turkish
AIM:
Hydatid cystic disease is an endemic parasitic disease that is common in the world. We aimed to review the demographic, clinical and laboratory findings, and treatments and outcomes of children with hydatid cyst disease, and to determine the factors affecting treatment response in two pediatric pulmonology centers in the central region of Turkey.
MATERIAL AND METHODS:
|
https://www.ncbi.nlm.nih.gov/pubmed/31651803 NAFLD
J Pediatr Gastroenterol Nutr. 2019 Oct 23. doi: 10.1097/MPG.0000000000002523. [Epub ahead of print]
Childhood Obesity: A Risk Factor for Non-alcoholic Fatty Liver Disease in Adolescence.
Benítez VC1, Alberti G1, Uauy R1,2, Pereira A2, García C1, de Barbieri F1, Corvalán C2, Santos JL1, Mericq V3, Villarroel L1, Gana JC1.
Abstract
Non-alcoholic fatty liver disease (NAFLD), defined as fat accumulation >5% in hepatocytes, may progress to fibrosis or cirrhosis later in life. NAFLD prevalence in adolescents has increased significantly in direct relation with obesity prevalence. Fatty liver has become the most frequent indication for liver transplantation in adults.
OBJECTIVE:
|
https://www.ncbi.nlm.nih.gov/pubmed/31638005 Hepatitis A
Indian Pediatr. 2019 Sep 15;56(9):741-744.
Hepatitis A Virus-related Pediatric Liver Disease Burden and its Significance in the Indian Subcontinent.
Sood V1, Lal BB1, Gupta E2, Khanna R1, Siloliya MK1, Alam S3.
Abstract
OBJECTIVE:
To study the Hepatitis A virus (HAV) infection-related pediatric liver disease burden.
METHODS:
Hospital records of 431 children (age <18 y) diagnosed to be suffering from acute HAV infection during 2011 to 2018 were extracted and analyzed. Additionally, a seroprevalence study was done on 2599 participants (696 children and 1903 adults).
RESULTS:
|
https://www.ncbi.nlm.nih.gov/pubmed/31652022 Transplant
Pediatr Transplant. 2019 Oct 25:e13608. doi: 10.1111/petr.13608. [Epub ahead of print]
The use of urinary biomarkers to predict acute kidney injury in children after liver transplant.
Fuhrman DY1,2,3, Kellum JA2, Joyce EL2,3, Miyashita Y3, Mazariegos GV4, Ganoza A4, Squires JE5.
Abstract
BACKGROUND:
AKI after pediatric liver transplantation is associated with increased morbidity and mortality. The role of urinary biomarkers for the prediction of AKI in pediatric patients after liver transplantation has not been previously reported. The primary objective of this prospective pilot study was to determine the predictive capabilities of urinary KIM-1, NGAL, TIMP-2, and IGFBP7 for diagnosing AKI.
METHODS:
|
https://www.ncbi.nlm.nih.gov/pubmed/31646984 Thalessemia
BMC Pediatr. 2019 Oct 23;19(1):375. doi: 10.1186/s12887-019-1744-8.
Evaluation of the vitamin D and biomedical statuses of young children with β-thalassemia major at a single center in southern China.
Yu U1, Chen L1, Wang X1, Zhang X1, Li Y1, Wen F1, Liu S2.
Abstract
BACKGROUND:
In young children, β-thalassemia major (β-TM) is associated with potentially severe clinical characteristics, including poor growth, feeding difficulties, hepatosplenomegaly, bone metabolic disorders, and skeletal abnormalities.
METHODS:
|
https://www.ncbi.nlm.nih.gov/pubmed/31655133 NAFLD
J Hepatol. 2019 Oct 23. pii: S0168-8278(19)30613-0. doi: 10.1016/j.jhep.2019.10.011.
β-Klotho gene variation is associated with liver damage in children with NAFLD.
Dongiovanni P1, Crudele A2, Panera N3, Romito I4, Meroni M5, De Stefanis C6, Palma A7, Comparcola D8, Fracanzani AL9, Miele L10, Valenti L11, Nobili V12, Alisi A13.
Abstract
BACKGROUND AND AIM:
|
https://www.ncbi.nlm.nih.gov/pubmed/31651665 Chronic liver disease
J Pediatr Gastroenterol Nutr. 2019 Oct 22. doi: 10.1097/MPG.0000000000002521. [Epub ahead of print]
Efficacy And Safety Of Sodium Benzoate In The Management Of Hyperammonemia in Decompensated Chronic Liver Disease of the Childhood- A Double Blind Randomised Controlled Trial.
Snehavardhan P1, Lal BB, Sood V, Khanna R, Alam S.
Abstract
OBJECTIVE:
The objective was to evaluate the efficacy and safety of sodium benzoate in the management of hyperammonemia and hepatic encephalopathy in decompensated chronic liver disease (CLD).
METHODS:
|
https://www.ncbi.nlm.nih.gov/pubmed/31657145 NAFLD
Pediatr Obes. 2019 Oct 27. doi: 10.1111/ijpo.12581. [Epub ahead of print]
Severe obesity is associated with liver disease severity in pediatric non-alcoholic fatty liver disease.
Seth A1, Orkin S2, Yodoshi T2, Liu C3, Fei L3, Hardy J2, Trout AT4, Arce Clachar AC2, Bramlage K2, Xanthakos S2, Mouzaki M2.
Abstract
BACKGROUND:
Paediatric non-alcoholic fatty liver disease (NAFLD) is highly prevalent among children with obesity. The primary objective of this study was determining whether obesity severity is associated with NAFLD severity. By using paediatric classifications for severe obesity, clinicians may be able to better risk stratify patients, which in turn would guide more effective management and treatment.
METHODS:
|
https://www.ncbi.nlm.nih.gov/pubmed/31651666 NAFLD
J Pediatr Gastroenterol Nutr. 2019 Oct 22. doi: 10.1097/MPG.0000000000002527. [Epub ahead of print]
Community Socioeconomic Deprivation and Non-Alcoholic Fatty Liver Disease Severity.
Orkin S1, Brokamp C2,3, Yodoshi T1, Trout AT4,3,5, Liu C2, Meryum S1, Taylor S6, Wolfe C2, Sheridan R7, Seth A8, Bhuiyan MAN2, Ley S9,3, Arce-Clachar AC1,3, Bramlage K1, Kahn R10, Xanthakos S1,3, Beck AF6,3,10,11, Mouzaki M1,3.
Abstract
BACKGROUND AND OBJECTIVES:
|
https://www.ncbi.nlm.nih.gov/pubmed/31663387 Hepatitis B
Expert Rev Gastroenterol Hepatol. 2019 Oct 30. doi: 10.1080/17474124.2019.1686975. [Epub ahead of print]
Updates in the management of hepatitis B in children.
Lai MW1,2,3, Chang MH4.
Abstract
|